Aquaculture R&D firm acquires Elanco facilityDecember 24, 2019Aligning with its international restructuring plans, Elanco Animal Health has sold its aqua research and development (R&D) facility in Victoria, Prince Edward Island (PEI), Canada.
SPONSORED CONTENTFind success with your parvovirus protocolDiscover our Canine Parvovirus Monoclonal Antibody: puppies treated with CPMA experienced a 93% real-world survival rate, and were able to head home from the clinic almost two days earlier.1,2 + Read More